DCF — ST VINCENT INFIRMARY MEDICAL CENTER
Enterprise Value: $-347.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-347.3M
Enterprise Value
$-116.2M
PV of Cash Flows
$-231.1M
PV of Terminal Value
$-372.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $404.5M | $-18.2M | -4.0% | $-35.3M | $-32.1M |
| Year 2 | $416.6M | $-14.6M | -3.0% | $-32.2M | $-26.6M |
| Year 3 | $429.1M | $-10.7M | -2.0% | $-28.9M | $-21.7M |
| Year 4 | $442.0M | $-8.8M | -2.0% | $-27.5M | $-18.8M |
| Year 5 | $455.2M | $-8.0M | -2.0% | $-27.2M | $-16.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-347.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$392.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.049999999618022886
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5